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Background: Human Rhinovirus (HRV) has been identified as the most common cause of acute
respiratory infections and hospitalizations in premature children. It is unclear if premature
children are more susceptible to HRV due to their decreased pulmonary reserve or because
they have enhanced lower airway reactivity to HRV.
Methods: We conducted a retrospective analysis of the clinical respiratory presentation of all
PCR-confirmed HRV infections in full-term and premature children aged 3 years in our institu-
tion. Standardized respiratory distress scores were developed to examine lower airway obstruc-
tion (i.e., wheezing, hyperinflation, and sub-costal retractions) along with markers of decreased
pulmonary reserve (hypoxemia and tachypnea) in young children with HRV infections. Demo-
graphic and clinical variables were obtained from reviewing electronic medical records (EMR).
* Corresponding author. Division of Pediatric Pulmonology and Sleep Medicine, Children’s National Medical Center, Center for Genetic
Medicine Research, 111 Michigan Avenue, NW, Washington, DC 20010, USA.
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Results: This study included a total of 205 children; 71% of these children were born full-term
(>37 weeks gestation), 10% preterm (32e37 weeks) and 19% severely premature (<32 weeks).
Our results demonstrated that: 1) HRV infections in the first 3 years of life were associated with
higher overall respiratory distress scores in severely premature children relative to children born
preterm or full-term; 2) HRV-infected severely premature children 3 years old were more
likely to have lower airway obstruction than HRV-infected children born preterm or full-term;
and 3) other clinical signs of respiratory distress such as tachypnea and hypoxemia were not
more common in severely premature than in preterm and full-term children during an HRV
infection.
Conclusions: Our results indicate that HRV infections in severely premature children are associ-
ated with lower airway obstruction rather than hypoxemia or tachypnea. The latter suggests
that enhanced airway reactivity is the underlying mechanism for the increased susceptibility
to HRV in severely premature children. Longitudinal studies are needed to understand why pre-
mature babies develop airway hyper-reactivity to HRV and the long-term effects of early HRV
infection in this population.
Copyright ª 2017, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
1. Introduction
Human rhinovirus (HRV) is the most common cause of
asthma exacerbation in all ages1 and recent evidence
demonstrates that HRV causes severe respiratory infections
in premature children.2e4 In fact, HRV is the most common
reason for hospitalization in this population.4 Despite the
clinical connection between HRV and prematurity, it is still
unclear if premature children are more susceptible to se-
vere HRV infections due to their underlying decreased
pulmonary reserve or because premature birth itself in-
creases the susceptibility to develop enhanced airway
reactivity triggered by HRV.
Prematurity is associated with chronic lung disease (CLD)
characterized by hypoxemia due to abnormal alveolarization
leading to simplified gas-exchange units.5 Interestingly, in
addition to CLD, premature birth is increasingly recognized as
a major risk factor for the development of the asthmatic
condition,6,7 although the underlying mechanisms of this as-
sociation are presently unknown. It is also well-established
that premature children are at high risk of developing se-
vere lower respiratory tract infections caused by para-
myxoviruses such as Respiratory Syncytial Virus (RSV) and
Human Metapneumovirus (HMPV), which exacerbate under-
lyinghypoxemia andCLD.8,9 In contrast to RSVorHMPV,which
have been shown to induce lung injury and increased airway
oxidative stress,10HRV ismostly associatedwith the induction
of Th2-driven allergic inflammation leading to airway hyper-
reactivity (AHR) and asthma exacerbations.1
The aim of this paper is to describe the clinical pheno-
type of HRV infections in hospitalized young children and to
better understand the potential mechanisms by which this
virus causes severe respiratory disease in this vulnerable
population of severely premature children. Given that the
pathogenic role of HRV was primarily limited to the induc-
tion and/or exacerbation of AHR in high-risk groups (e.g.,
asthma, COPD),1 our hypothesis was that in the group of
young children requiring hospitalization due to HRV infec-
tion, those born severely premature (<32 weeks gestational
age), would have a significantly higher probability to pre-
sent signs of lower airway obstruction (e.g., wheezing) and
air trapping/hyperinflation (e.g., sub-costal retractions)
relative to full-term individuals. In contrast, we postulated
that other signs of respiratory distress not typically asso-
ciated with AHR, including hypoxemia and tachypnea,
would be similarly present in premature vs. full-term chil-
dren hospitalized with HRV infection.
2. Materials and methods
2.1. Study subjects
We conducted a retrospective cross-sectional analysis of a
cohort of children 3 years of age admitted with HRV
infection, confirmed by PCR analysis, to the Children’s
National Medical Center (CNMC) in 2014. Viral PCR was
performed on subjects who presented to the hospital with
suspected viral respiratory tract infection at the discretion
of the clinician. We included children with positive PCR for
HRV and excluded individuals with mixed viral infections
(HRV mixed with other viruses) to only focus on HRV. Pa-
tients with significant co-morbidities such as cardiorespi-
ratory conditions (other than prematurity), genetic
syndromes and immunosuppression were excluded from the
study. This study was approved by the Institutional Review
Board at the Children’s National Medical Center.
2.2. Clinical and demographic variables
Clinical and demographic variables were obtained by
reviewing electronic medical records (EMR) at CNMC. De-
mographic variables comprised gestational age in weeks,
age, gender, and ethnicity. Other clinical variables included
tachypnea, retractions, abnormal breath sounds
(wheezing), oxyhemoglobin saturation values by pulse ox-
imetry (SaO2), and supplemental oxygen (O2) requirement
relative to patient’s baseline. For the purpose of the study,
clinical parameters were characterized as binary outcomes
for the following: severe prematurity defined a priori by a
gestational age of less than 32 weeks to include extremely
preterm and very preterm subjects based on World Health
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Organization (WHO) definition of prematurity11e13 and ox-
ygen supplementation. Tachypnea was stratified and scored
in groups (0e3) according to respiratory rate definitions
used in bronchiolitis scores as follows: 0 for <30 breaths per
minute (bpm); 1 for 30e45 bpm; 2 for 46e60 bpm and 3 for
>60.8,14,15 Stratified wheezing severity (0e3) was also
defined based on distress scores14 as 0 for none; 1 for
expiratory only; 2 for inspiratory (expiratory) and 3 for
audible without stethoscope or silent chest (minimal or no
air entry) Z 3.
2.3. Clinical evaluation of viral respiratory tract
infection severity based on lower airway
obstruction and respiratory distress
As previously described,8 to retrospectively assess overall
clinical severity of HRV infection, we recorded wheezing,
retractions, supplemental O2 needed and tachypnea at the
initial presentation based on EMR and combined these into
the respiratory distress score (0e10). For this score, we
used a stratified value for tachypnea (0e3) and combined
assigned values with the binary need of O2 (0e2), stratified
presence of wheezing (0e3) and retractions (0e2), yielding
a total maximal value of 10 points (Fig. 1). Of note, the four
clinical variables included in this respiratory distress score
were selected because they represented the main pheno-
typical features of viral bronchiolitis in children,8,16 lower
airway obstruction and respiratory distress, and they were
the parameters included in bronchiolitis scores validated by
our group (Modified Wood’s Clinical Asthma score [M-WCAS]
and Tal severity score).8,14,15
2.4. Statistical analysis
Data were analyzed using the software SAS version 9.3 (SAS
Institute Inc., Cary, NC, USA). Descriptive statistics were
used to calculate the prevalence of HRV. Collected de-
mographic and clinical data were compared with the use of
a Chi-square test (categorical variables) or T-test or Wil-
coxon rank-sum test as appropriate for continuous vari-
ables. Comparisons between GA groups were done with
ANOVA and post-hoc Bonferroni adjustment. Significance
was taken at the P < 0.05 level.
Figure 1 Respiratory distress assessment during Rhinovirus infection. A. parameters used to examine total respiratory distress
and individual contribution in lower airway obstruction and parenchymal lung disease. Wheezing was stratified as (þ) expiratory
only; (þþ) inspiratory (expiratory) and (þþþ) for audible without stethoscope or silent chest (minimal or no air entry); B.
Respiratory distress assessment in children <3 yr of age hospitalized with rhinovirus infection (n Z 205). Black bars represent
subjects born <32 wks gestational age; white bars correspond to individuals born >32 wks. Data presented as 95% confidence
interval of the mean.
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3. Results
3.1. Rhinovirus a common cause of hospitalization
in premature children
We first examined the proportion of children born before
term at 37 weeks gestation in our study group of hospital-
ized children with PCR-confirmed HRV infection. Among the
205 subjects included in this study, we identified that 34%
(n Z 69) of children hospitalized with HRV infection were
born before term gestation. The majority of these prema-
ture children were born at less than 32 weeks gestation
(22%; n Z 47). We did not identify significant differences in
the baseline characteristics, including demographics and
family history of asthma, of the children born full term
(>37 weeks gestation), preterm (32e37 weeks gestation) or
severely premature (<32 weeks gestation) except for black
ethnicity, which was more common in the severely pre-
mature group. Comparison of the baseline characteristics
of these three groups is presented in Table 1.
3.2. Respiratory distress severity evaluation in
children hospitalized with human rhinovirus
infection
We previously validated bronchiolitis scores in hospitalized
children with viral respiratory infections.14 Taking the
physiological parameters included in those scores, we
recently developed a respiratory distress scale to be used
retrospectively in hospitalized children with respiratory
viral infections.8 Fig. 2 illustrates the parameters included
in our respiratory distress score. It includes four parameters
balanced to equally cover two main domains: parenchymal
lung disease assessment (i.e., tachypnea and hypoxemia)
and lower airway obstruction assessment (i.e., wheezing
and sub-costal retractions). Hypoxemia and tachypnea are
signs of involvement of parenchymal alveolar gas-exchange
units during viral infection.8,16 Viral-induced wheezing is
indicative of narrowed lumen in the conductive airways and
sub-costal retractions is a sign of air-trapping/
hyperinflation causing flattening of the diaphragm.8,16
We first used these respiratory distress parameters to
examine the overall clinical severity of HRV in hospitalized
children. As expected, we identified that individuals born
<32 weeks gestation had overall higher distress severity
(total score 6.3; 95% CI 5.6e7) relative to children born
either full term or preterm (4.6; 95% CI 4.1e5.1). Then we
conducted phenotypical characterization using individual
parameters for parenchymal lung disease assessment and
lower airway obstruction assessment. This analysis showed
that the lower airway obstruction component (wheezing
and sub-costal retractions) was significantly increased in
severely premature children relative to individuals born
preterm or full term (Fig. 1B). By contrast, we did not
observe significant differences in the parenchymal lung
disease component (hypoxemia and tachypnea) (Fig. 1B).
To confirm these findings we performed an alternative
analysis in which we examined individually the degree of
tachypnea or the probability of needing supplemental ox-
ygen (Fig. 2A) as well as the absolute values of respiratory
rate and oxygen saturation (SaO2) at presentation to the
hospital during HRV infection (Fig. 2B). This secondary
analysis did not identify statistically significant differences
in respiratory rate or oxygenation parameters in severely
premature children versus those born preterm on full term.
3.3. Dose effect of the degree of prematurity and
probability of wheezing in children hospitalized
with rhinovirus infection
Recent evidencedemonstrates that thedegreeofprematurity
has a dose effect in assessing the risk of developing asthma.7
We have also found that there is relative dose response of
prematurity in the secretion of airway Th2 cytokines during
HRV infection.13 Specifically, the group of children born <32
weeks gestation had the strongest Th2 response to HRV, with
gradual decrease in individuals born at 32e37weeks gestation
and Th2 response was even lower in full term children with
HRV.13 To investigate whether there was also a dose effect of
prematurity in the degree of lower airway obstruction during
HRV infection, we examined the probability of developing
wheezing or sub-costal retractions during HRV infection as a
function ofGA. Thedata showed the probability of developing
wheezing and sub-costal retractions increased with lower
gestational age (Fig. 3), with the highest risk seen in the
cluster of children born at <32 weeks gestation.
4. Discussion
Human rhinovirus infection (HRV) is the top cause of hos-
pitalization in premature children.4 It is unclear whether
HRV causes severe respiratory disease in premature chil-
dren primarily (due to the underlying parenchymal lung
disease leading to worsening hypoxemia and tachypnea) or
Table 1 Baseline characteristics for subjects.
Term (>37 wks GA) Preterm (32e37 wks GA) Severe Premature
(<32 wks GA)
N (%) 135 (66) 22 (11) 47 (23)
Age (yrs.), mean (SD) 1.35 (1.0) 1.22 (0.8) 1.5 (1.0)
Male, n (%) 78 (58) 14 (63) 33 (70)
Black, n (%)* 64 (47) 6 (27) 31 (66)
Family history of asthma, n (%) 27 (20) 2 (9) 6 (13)
Demographics for all study subjects (n Z 205) hospitalized with acute rhinovirus infection. GA Z gestational age, SDZ Standard de-
viation, *P value< 0.05.
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whether HRV is mainly a trigger of wheezing and AHR in
premature children similar to its well-established role in
asthma exacerbations.1 The main finding of our study is
that premature children hospitalized due to HRV infection
have primarily clinical signs of lower airway obstruction
which are typically seen during viral-induced airway hy-
peractivity. This study provides new evidence that HRV
infection in premature children, similarly to what has been
previously described in the asthmatic condition,1 seems to
trigger AHR leading to wheezing, air trapping, and more
severe respiratory disease which ultimately causes an in-
crease in health care utilization2e4 and increased risk for
hospitalization.4
In susceptible individuals HRV is known to activate im-
mune signaling pathways that promote Th2 airway inflam-
mation17e21 leading to increased mucus secretion and
bronchoconstriction.17e21 Animal models of allergic lung
inflammation and human-based research have shown that
HRV induces the secretion of airway epithelial Th2-
promoting cytokines such as thymic stromal lymphopoie-
tin (TSLP), IL-25 and IL-33.17 The secretion of these cyto-
kines occurs after an innate recognition of receptors
present in the airway epithelial cell including toll-like re-
ceptor (TLR)-3, MDA 5 and RIG-I,22 which activate down-
stream interferon-responsive genes and other pro-
inflammatory cytokines through the activation of NFKB
signaling.22,23 Interestingly, we have recently shown that
premature infants have an airway immune response during
viral infections that closely resembles the Th2-driven
inflammation seen in the asthmatic condition.13,24 As a
result, premature infants have an increased airway secre-
tion of the classical Th2 cytokines IL-4 and IL-13 in response
to natural HRV infection.13 Expanding these findings, our
current study suggests that HRV induces AHR in premature
infants, which is manifested as lower airway obstruction.
Clinically, the best markers of AHR in infants are wheezing
and hyperinflation16 which are best assessed by ausculta-
tion during forced exhalation maneuvers and visual in-
spection of sub-costal retractions due to air-trapping
leading to diaphragm flattening.16 These clinical findings
suggest that HRV effect in the lungs of premature infants is
mostly due to mucosal inflammation and bronchocon-
striction leading to lower airway obstruction, as recently
suggested in animal models of early rhinovirus infection.17
Prior studies have investigated the presence of lower
airway obstruction in premature children.25e28 Premature
birth is associated with alveolar simplification due to
impaired secondary septation leading to reduced lung ca-
pacity as well as increased airway resistance due to altered
alveolar airway radial traction.5 These findings have been
confirmed through the use of pulmonary function testing25-28
and studies on the effects of viral infections28 have shown
airway resistance is significantly increased during respiratory
infections in premature infants.28 In addition, studies pri-
marily based on the report of wheezing have identified HRV
is associated with frequent health care utilization mostly
due to recurrent lower airway respiratory symptoms.2 To
extend these prior investigations, we conducted the first
phenotypical characterization of HRV infection in premature
Figure 2 Hypoxemia and tachypnea during Rhinovirus
infection. A. Boxplots (median and interquartile ranges) of
respiratory rate (RR) pulse-oximetry (SaO2) at admission during
rhinovirus infection. B. Values of stratified tachypnea and need
for supplemental O2 during rhinovirus infection. Black bars
represent subjects born <32 wks gestational age; white bars
correspond to individuals born >32 wks. Data presented as 95%
confidence interval of the mean. Data included all hospitalized
children with rhinovirus infection (n Z 205). NS Z non-signif-
icant (p > 0.05).
Figure 3 Dose effect of prematurity in the probability of
wheezing or sub-costal retractions during Rhinovirus infec-
tion. Data included all hospitalized children 0e3 years old with
rhinovirus infection (n Z 205). Data presented as 95% confi-
dence interval of the mean by gestational (GA) clusters. P
values obtained by ANOVA and post-hoc Bonferroni adjustment.
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infants requiring hospitalization, using standardized clinical
scales for respiratory distress.8,14,15 The respiratory distress
scores used in our current study were based on widely used
clinical scales to examine bronchiolitis severity which had
been previously validated by our group in the setting of
hospitalized children.14 These clinical scales include
different parameters such as hypoxemia e better quantified
as need of oxygen relative to baseline8 together with
tachypnea (absolute and stratified).8,14,15 It is important to
emphasize that in clinical practice respiratory rate (and
tachypnea) should be classified according the normal range
of different age population. For research purposes we
implemented a scoring system that could not take respira-
tory rate as a continuous variable; it needed to be coded in a
numerical scale to allow combination with other clinical
parameters (e.g., wheezing, retractions, O2). The reason
why we selected this tachypnea stratification (<30, 30e60,
>60 bpmZ 0,1,2,3) was our prior studies demonstrated that
alone and, in combination with other parameters, it had
optimal performance in clinical scoring in young children of
different age ranges.8,14,15 Specifically, it has adequate cri-
terion validity, adequate construct validity, adequate inter-
rater agreement, adequate sensitivity to change, and
appropriate usability for infants hospitalized for acute
bronchiolitis.8,14,15 Using this approach we have identified
hypoxemia and tachypnea are strong predictors of the need
for advanced support including high-flow devices, positive
airway pressure, and mechanical ventilation in lower respi-
ratory infections.8 Our results showed that hospitalized
premature infants with HRV had overall higher respiratory
distress scores relative to full-term children hospitalized due
to HRV infection. However, the increase in respiratory
distress was not due to higher levels of hypoxemia or
tachypnea, which would be indicative of decreased respi-
ratory reserve, CLD or parenchymal lung disease leading to
ventilation/perfusion (V/Q) mismatch. By contrast, we
observed a clear difference in the markers of lower airway
obstruction, wheezing and sub-costal retractions in prema-
ture children with HRV. Collectively, these findings indicated
that the main difference in the presentation of HRV infec-
tion between premature and full-term hospitalized children
was the presence of lower airway obstruction and not
worsening of respiratory reserve with signs of parenchymal
lung disease.
In the current study we categorized tachypnea/hypox-
emia relating to parenchymal disease and wheezing/sub-
costal retractions to lower airway obstruction (Fig. 1). It is
important to clarify that there is no solid clinical evidence
that tachypnea and hypoxemia relate to parenchymal dis-
ease and not to airway obstruction. Our scoring classifica-
tion should not be extrapolated to all respiratory conditions
and this categorization should be understood in the specific
context of viral respiratory infections of infants. Our
rationale was partly based on our recent HMPV clinical
study in premature children,8 in which we found that
parenchymal disease (verified by CXR infiltrates) was
associated with hypoxemia/tachypnea and not wheezing
(clinical marker of lower airway obstruction). Hypoxemia/
tachypnea predicted poor clinical outcome as it was linked
to a greater probability of respiratory failure and the need
for more advanced support in the intensive care unit.8 We
speculate that hypoxemia results from V/Q mismatching
and tachypnea from the reduction in lung compliance due
to a localized parenchymal disease (infiltrate) during HMPV
infection. In our current RV study we observed that
wheezing predominated over hypoxemia/tachypnea in the
same population (premature infants). These findings sug-
gest that the respiratory distress assessment of viral in-
fections of infants needs to consider hypoxemia/tachypnea
and wheezing (e.g., lower airway obstruction) separately to
delineate phenotypical differences that may have signifi-
cant impact in clinical outcomes.
Another important finding of our current study was the
presence of a robust doseeresponse association between
degree of prematurity and the probability of wheezing in
premature children hospitalizedwithHRV. As shown in Fig. 3,
there was a direct relationship (dose-effect) between pre-
maturity, expressed as gestational age, and the likelihood of
wheezing HRV infections. The greatest probability of
wheezingwas identified in the group of “severe prematurity”
with less than 32 weeks gestation. These data resemble the
recently identified dose effect of prematurity and risk of
asthma compared with term children, at ages 0e5 and 6e9
years.7 This study included 2540 longitudinal cases from the
BostonBirthCohort, inwhich the investigators identified that
there was a significant increase in the risk of developing
asthma when prematurity was clustered according to gesta-
tional age (to refine the assessment of the degree of pre-
maturity) with the highest odds of asthma being observed in
premature children <32 weeks gestation (OR 6.2 [95% CI:
3.3e11.6]; P:0.001).7 This is the sameprematurity clusterwe
identified with the highest probability of wheezing during
HRV infection. Given that HRV-induced wheezing in early life
is the strongest risk factor for persistence of wheezing and
subsequent development of asthma,29 future studies are
needed to investigate the interplay and potential additive
effects of prematurity and HRV in the pathogenesis of the
asthmatic condition. These studies should adjust for addi-
tional factors that may favor prematurity and severity of
rhinovirus infections including differences in family eco-
nomic status, sibling numbers and nutritional status. Future
research should also include more objective functional pa-
rameters and biomarkers to better define respiratory phe-
notypes in premature infants at baseline and during acute
respiratory infections.
In summary, our study provides new clinical evidence
demonstrating HRV infections in severely premature chil-
dren lead to lower airway obstruction as demonstrated by
wheezing and hyperinflation rather than hypoxemia or
tachypnea. The latter suggests enhanced airway reactivity
is the underlying mechanism for the increased susceptibil-
ity to HRV in severely premature children. This novel finding
adds to the increasing evidence that premature birth is
associated with the pathogenesis of the asthmatic condi-
tion. Longitudinal studies are needed to understand why
premature babies develop airway hyper-reactivity to HRV
and what long-term effects of early HRV infection are in
this population.
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